Susquehanna Portfolio Strategies’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-68,213
Closed -$6.35M 840
2026
Q1
$6.35M Hold
68,213
0.09% 266
2025
Q4
$5.48M Sell
68,213
-2,873
-4% -$241K 0.08% 295
2025
Q3
$6.94M Buy
71,086
+3,220
+5% +$259K 0.11% 250
2025
Q2
$4.73M Buy
+67,866
New +$3.87M 0.1% 227
2024
Q1
Sell
-5,143
Closed -$667K 780
2023
Q4
$667K Buy
+5,143
New +$709K 0.01% 702

Other funds holding ACLS

Susquehanna Portfolio Strategies's ACLS Position: Q2 2026 in Review

Susquehanna Portfolio Strategies sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 68,213 shares — an estimated $6.35M sold.

Susquehanna Portfolio Strategies first reported a position in ACLS in Q4 2023 and held it in 5 quarters. The position peaked at $6.94M in Q3 2025. 439 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Susquehanna Portfolio Strategies reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 68,213 Axcelis shares in Q2 2026, an estimated $6.35M.
  • Susquehanna Portfolio Strategies first reported a position in Axcelis in Q4 2023 and held it in 5 quarters.
  • Susquehanna Portfolio Strategies's Axcelis position peaked at $6.94M in Q3 2025.
  • 439 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.